The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing ...

Calorie restriction, physical activity and the drug dapagliflozin caused 44% of participants in a small trial to enter ...

The combined regimen achieved a higher remission rate than calorie restriction alone in people with overweight or obesity and ...

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor ...

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.